Intended for healthcare professionals

  1. Research
  2. Underreporting of...
  3. Underreporting of suspected adverse drug reactions to newly marketed (“black triangle”) drugs in general practice: observational study
Papers

Underreporting of suspected adverse drug reactions to newly marketed (“black triangle”) drugs in general practice: observational study

BMJ 1998; 317 doi: https://doi.org/10.1136/bmj.317.7151.119 (Published 11 July 1998) Cite this as: BMJ 1998;317:119

Related articles

See more

Cited by...

  • Improved Outcomes Associated with Limiting Identification of Candida spp. in Respiratory Secretions
  • Advances in targeted therapy: safety of biological agents
  • Dissemination of Information on Potentially Fatal Adverse Drug Reactions for Cancer Drugs From 2000 to 2002: First Results From the Research on Adverse Drug Events and Reports Project
  • Survival after cardiac arrest outside hospital
  • Cardiac risks with beta agonists
Back to top